Article Versions Notes

Zavaglio F, Cassaniti I, Sammartino JC, Tonello S, Sainaghi PP, Novelli V, Meloni F, Lilleri D, Baldanti F. mRNA BNT162b Vaccine Elicited Higher Antibody and CD4⁺ T-Cell Responses than Patients with Mild COVID-19. Microorganisms. 2022; 10(6):1250. https://doi.org/10.3390/microorganisms10061250

Zavaglio, Federica, Irene Cassaniti, Josè Camilla Sammartino, Stelvio Tonello, Pier Paolo Sainaghi, Viola Novelli, Federica Meloni, Daniele Lilleri, and Fausto Baldanti. 2022. "mRNA BNT162b Vaccine Elicited Higher Antibody and CD4⁺ T-Cell Responses than Patients with Mild COVID-19" Microorganisms 10, no. 6: 1250. https://doi.org/10.3390/microorganisms10061250

Zavaglio, F., Cassaniti, I., Sammartino, J. C., Tonello, S., Sainaghi, P. P., Novelli, V., Meloni, F., Lilleri, D., & Baldanti, F. (2022). mRNA BNT162b Vaccine Elicited Higher Antibody and CD4⁺ T-Cell Responses than Patients with Mild COVID-19. Microorganisms, 10(6), 1250. https://doi.org/10.3390/microorganisms10061250